problems with glp-1 drugs Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity Long-term Success of GLP-1s Hinges

Here's a breakdown of what we know so far: Type of Drug: Danuglipron belongs to a class of drugs called GLP-1 receptor agonists

While oral formulations offer the convenience of a pill compared to traditional injections, this shift also raises important compliance considerations

- **Curb appetite:** Helping individuals feel full, potentially leading to reduced food intake

NOC= Notice of Compliance.

The World Obesity Atlas 2024 reports over 1.5 billion projected cases by 2035, highlighting its growing threat among pediatric and adult populations globally

These assets aim to move beyond the current weekly injection paradigm, signalling a future where extended dosing intervals could become central to maintenance strategies [16].